RKWAF — Rockwool A/S/ADR

OTC · Unknown · Unknown · CIK 1969729 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 906,000,000 616,000,000 120,000,000 -85,000,000 4,037,000,000 207,000,000 1,209,000,000
Dec 2025 967,000,000 645,000,000 137,000,000 -332,000,000 3,642,000,000 108,000,000 901,000,000
Sep 2025 963,000,000 645,000,000 150,000,000 122,000,000 4,048,000,000 376,000,000 979,000,000
Jun 2025 988,000,000 675,000,000 153,000,000 122,000,000 4,001,000,000 352,000,000 969,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$610,000,000
Investing CF
$-475,000,000
Financing CF
$-218,000,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$2.44
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$2,798,000,000
Inventory
$374,000,000
Receivables
ST Investments
EBIT TTM
Pretax Income TTM
$193,000,000
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,877,000,000 594,000,000 28,000,000 3,642,000,000 901,000,000 610,000,000
Dec 2024 3,855,000,000 684,000,000 550,000,000 3,888,000,000 802,000,000 817,000,000
Dec 2023 3,620,000,000 531,000,000 389,000,000 3,554,000,000 750,000,000 707,000,000
Dec 2022 3,907,000,000 402,000,000 273,000,000 3,428,000,000 848,000,000 394,000,000

Peers — same industry

TickerNameMarket CapLastDaily %
SPY SPDR S&P 500 ETF TRUST $680.04B $740.96
KXIAY Kioxia Holdings Corporation/ADR $316.73B $58.00
KLAC KLA CORP $311.85B $238.73
QQQ INVESCO QQQ TRUST, SERIES 1 $284.02B $722.51
IBM INTERNATIONAL BUSINESS MACHINES CORP $246.58B $262.35

News headlines (Yahoo Finance, 1h cache)

Rockwool (CPSE:ROCK B) Stock Fair Value Edges Higher After Analyst Target Revisions
2026-06-13 03:10 · Yahoo
Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital
2026-06-11 13:34 · Yahoo
Total number of shares and voting rights in ROCKWOOL A/S
2026-05-29 10:57 · Yahoo
Report on transactions of executives and related parties in ROCKWOOL A/S shares
2026-05-22 10:52 · Yahoo
Rockwool AS (RKWBF) Q1 2026 Earnings Call Highlights: Navigating Growth Amidst Market Challenges
2026-05-20 19:01 · Yahoo
Resilient first quarter revenue growth amid global uncertainty
2026-05-19 08:53 · Yahoo
Reduction of the share capital
2026-05-18 08:51 · Yahoo
Assessing Rockwool (CPSE:ROCK B) Valuation After 2026 Outlook Upgrade And Higher Investment Plans
2026-05-14 04:38 · Yahoo
ROCKWOOL adjusts upwards its outlook for full-year revenue growth and investments for 2026
2026-05-11 11:31 · Yahoo
Restricted Share Unit Program
2026-04-15 17:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.